|
Name |
Alterporriol L
|
| Molecular Formula | C32H26O12 | |
| IUPAC Name* |
4,7-dihydroxy-1-methoxy-6-methyl-2-[(6R,7S,8S)-4,6,7,8-tetrahydroxy-1-methoxy-7-methyl-9,10-dioxo-6,8-dihydro-5H-anthracen-2-yl]anthracene-9,10-dione
|
|
| SMILES |
CC1=CC2=C(C=C1O)C(=O)C3=C(C(=CC(=C3C2=O)O)C4=CC(=C5C(=C4OC)C(=O)C6=C(C5=O)C[C@H]([C@]([C@H]6O)(C)O)O)O)OC
|
|
| InChI |
InChI=1S/C32H26O12/c1-10-5-11-12(6-16(10)33)26(38)23-21(25(11)37)17(34)7-13(29(23)43-3)14-8-18(35)22-24(30(14)44-4)28(40)20-15(27(22)39)9-19(36)32(2,42)31(20)41/h5-8,19,31,33-36,41-42H,9H2,1-4H3/t19-,31+,32+/m1/s1
|
|
| InChIKey |
HMIMHGZMSJACHB-YYAADSQRSA-N
|
|
| Synonyms |
Alterporriol L
|
|
| CAS | NA | |
| PubChem CID | 139587993 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 602.5 | ALogp: | 2.5 |
| HBD: | 6 | HBA: | 12 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 208.0 | Aromatic Rings: | 6 |
| Heavy Atoms: | 44 | QED Weighted: | 0.2 |
| Caco-2 Permeability: | -6.271 | MDCK Permeability: | 0.00000575 |
| Pgp-inhibitor: | 0.775 | Pgp-substrate: | 0.446 |
| Human Intestinal Absorption (HIA): | 0.86 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.993 |
| Blood-Brain-Barrier Penetration (BBB): | 0.002 | Plasma Protein Binding (PPB): | 94.94% |
| Volume Distribution (VD): | 0.362 | Fu: | 4.69% |
| CYP1A2-inhibitor: | 0.25 | CYP1A2-substrate: | 0.911 |
| CYP2C19-inhibitor: | 0.023 | CYP2C19-substrate: | 0.05 |
| CYP2C9-inhibitor: | 0.593 | CYP2C9-substrate: | 0.143 |
| CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.131 |
| CYP3A4-inhibitor: | 0.079 | CYP3A4-substrate: | 0.09 |
| Clearance (CL): | 6.243 | Half-life (T1/2): | 0.052 |
| hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.07 |
| Drug-inuced Liver Injury (DILI): | 0.939 | AMES Toxicity: | 0.463 |
| Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.893 |
| Skin Sensitization: | 0.195 | Carcinogencity: | 0.025 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.38 |
| Respiratory Toxicity: | 0.024 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004850 | ![]() |
1.000 | D01XWG | ![]() |
0.256 | ||
| ENC003769 | ![]() |
1.000 | D07VLY | ![]() |
0.251 | ||
| ENC003686 | ![]() |
1.000 | D0C9XJ | ![]() |
0.251 | ||
| ENC003974 | ![]() |
1.000 | D0T5XN | ![]() |
0.244 | ||
| ENC006071 | ![]() |
0.812 | D01XDL | ![]() |
0.241 | ||
| ENC003805 | ![]() |
0.806 | D03RTK | ![]() |
0.240 | ||
| ENC003610 | ![]() |
0.806 | D07MGA | ![]() |
0.234 | ||
| ENC006131 | ![]() |
0.718 | D0Z2LG | ![]() |
0.231 | ||
| ENC004851 | ![]() |
0.718 | D09LBS | ![]() |
0.231 | ||
| ENC000971 | ![]() |
0.718 | D06GCK | ![]() |
0.230 | ||